Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September

Rhea-AI Summary

Oncolytics Biotech Inc. (NASDAQ: ONCY), a clinical-stage immunotherapy company, has announced its participation in two upcoming investment conferences in September 2024. Chief Financial Officer Kirk Look will attend the H.C. Wainwright 26th Annual Global Investment Conference on September 11, while Chief Medical Officer Tom Heineman, M.D., Ph.D., will participate in the 2024 Cantor Global Healthcare Conference on September 19.

Both executives will engage in fireside chats at their respective events in New York City. The company will also conduct one-on-one investor meetings during these conferences. Webcasts of the presentations will be available on Oncolytics' Investor Relations page and archived for three months.

SAN DIEGO and CALGARY, AB, Sept. 6, 2024 /PRNewswire/ -- Oncolytics Biotech^® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Chief Financial Officer Kirk Look will participate in a fireside chat at the H.C. Wainwright 26^th Annual Global Investment Conference, which is taking place September 9-11, 2024 at the Lotte New York Palace Hotel in New York, NY. Chief Medical Officer Tom Heineman, M.D., Ph.D., will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference, which is taking place September 17-19, 2024 at the InterContinental New York Barclay Hotel in New York, NY. Additional details on the fireside chats can be found below.

Event: H.C. Wainwright 26^th Annual Global Investment Conference
Date: Wednesday, September 11, 2024
Time: 9:00 a.m. ET
Location: Lotte New York Palace Hotel, Holmes I Room - 4^th Floor
Webcast Link: Available by clicking here

Event: Cantor 2024 Global Healthcare Conference
Date: Thursday, September 19, 2024
Time: 10:55 a.m. ET
Location: InterContinental New York Barclay Hotel, Track 6 Morgan Suite
Webcast Link: Available by clicking here

Company management will also be participating in one-on-one investor meetings at the conferences. To schedule a meeting, please submit a request on the conference website, contact your H.C. Wainwright or Cantor Fitzgerald representative, or email jpatton@oncolytics.ca. 

Webcasts of the Company's presentations will also be available on the Investor Relations page of Oncolytics' website (LINK) and will be archived for three months.

About Oncolytics Biotech Inc.

Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype -- turning "cold" tumors "hot" -- through innate and adaptive immune responses to treat a variety of cancers.

Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA. For further information, please visit: www.oncolyticsbiotech.com or follow the company on social media on LinkedIn and on X @oncolytics.

Company Contact 
Jon Patton
Director of IR & Communication
jpatton@oncolytics.ca 

Investor Relations for Oncolytics
Timothy McCarthy
LifeSci Advisors
+1-917-679-9282
tim@lifesciadvisors.com  

Logo : https://mma.prnewswire.com/media/1762876/Oncolytics_Biotech_New_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/oncolytics-biotech-to-participate-in-fireside-chats-at-two-investment-conferences-in-september-302240554.html

SOURCE Oncolytics Biotech® Inc.

FAQ

When and where will Oncolytics Biotech (ONCY) participate in investment conferences in September 2024?

Oncolytics Biotech (ONCY) will participate in two investment conferences in September 2024: the H.C. Wainwright 26th Annual Global Investment Conference on September 11 at the Lotte New York Palace Hotel, and the 2024 Cantor Global Healthcare Conference on September 19 at the InterContinental New York Barclay Hotel, both in New York City.

Who will represent Oncolytics Biotech (ONCY) at the September 2024 investment conferences?

Chief Financial Officer Kirk Look will represent Oncolytics Biotech (ONCY) at the H.C. Wainwright conference on September 11, while Chief Medical Officer Tom Heineman, M.D., Ph.D., will attend the Cantor Global Healthcare Conference on September 19.

How can investors access the webcasts of Oncolytics Biotech's (ONCY) presentations at the September 2024 conferences?

Investors can access the webcasts of Oncolytics Biotech's (ONCY) presentations through the Investor Relations page on the company's website. The webcasts will be archived for three months after the events.

Will Oncolytics Biotech (ONCY) offer one-on-one investor meetings during the September 2024 conferences?

Yes, Oncolytics Biotech (ONCY) will offer one-on-one investor meetings during both conferences. Investors can schedule meetings through the conference websites, by contacting H.C. Wainwright or Cantor Fitzgerald representatives, or by emailing jpatton@oncolytics.ca.